Cruciate Ligament Diagnosis & treatment Market Research Report: Injury Type (Grade I, II, III), Product (Cement Implants, Cement-Less Implants), Indication (Osteoarthritis, RA), Treatment (Surgery), End-User (Hospitals, ASCs) – Global Forecast Till 2023
ID: MRFR/Pharma/4622-HCR | February 2021 | Region: Global | 100 pages
Market Scenario
The global cruciate ligament diagnosis and treatment market is expected to gain prominence over the forecast period (2018–2023). It is estimated that the cruciate ligament diagnosis and treatment market is expected to register a CAGR of 6.4% during the forecast period of 2018–2023.
A ligament is a band of tissue that holds the bones together, keeping the knee stable. Primarily these ligaments are broadly classified into cruciate ligament and collateral ligament. Further, these are divided into four primary ligaments, namely, Anterior Cruciate Ligament (ACL), Posterior Cruciate Ligament (PCL), Medial Collateral Ligament (MCL), and Lateral Collateral Ligament (LCL). The cruciate ligaments, i.e., the PCL and ACL are crossed ligaments that stabilize the joint while allowing a very large range of motion. Knee injuries are usually the most common musculoskeletal traumas among people, where the Anterior Cruciate Ligament (ACL) injury is one of the utmost frequent occurring knee injuries. Surgical reconstruction is the standard gold treatment for treating knee injuries. Increasing incidences of sports-related injuries have become a leading cause of soft tissue injuries worldwide. Athletes are most likely to injure the ACLs disabling complete stretching of their legs. A type of surgery that involves reconstruction of the ligament is known as ACL reconstruction that lies in the center of one’s knee with a graft. As per an article published in PubMed (2017), approximately 200,000 ACL injuries are registered each year on an average in the U.S. Cruciate ligaments repair is also the fastest growing segment for the soft tissue repair market globally. Subsequently, it is most commonly treated upon the athletes as they are mostly affected by ACL injuries owing to sport-related activities.
Numerous other factors such as growing number of knee reconstruction surgeries, increase in aging population coupled with rising incidences of diseases related to age such as rheumatoid arthritis and osteoarthritis, and increasing government assistance are continuously contributing to the growth of the global cruciate ligament diagnosis and treatment market.
Despite these drivers, there are some issues associated with the cruciate ligament diagnosis and treatment market. The complications associated with the treatment, lack of skilled or trained physicians, and poor healthcare system in low and middle-income countries may hamper the growth of the market.
Research Methodology
Market Research Future research is conducted by industry experts who offer insight into industry structure, market segmentation, treatment assessment, Competitive Landscape (CL), penetration, as well as on emerging trends. Besides primary interviews (~ 80%) and secondary research (~ 20%), their analysis is based on their years of professional expertise in respective industries. Our analysts also predict where the market will be headed in the next five to ten years, by analyzing historical trends and current market positions. Furthermore, the varying trends of segments & categories geographically presented are studied and are estimated based on primary & secondary research.
- Primary Research
The extensive primary research was conducted to gain a deeper insight of the market and the industry performance. In this particular report, we have conducted primary surveys (interviews) with the key level executives (VPs, CEOs, Marketing Directors, Business Development Managers, and many more) of the major players who are active in the market. In addition to analyzing the current and historical trends, our analysts predict where the market is headed, over the next five to ten years.
- Secondary Research
Secondary research was mainly used to collect and identify information useful for an extensive, technical, market-oriented, and commercial study of the cruciate ligament diagnosis and treatment market. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, & developments related to the market and treatment perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, SEC filings, journals, white papers, corporate presentations, company websites, the international organization of chemical manufacturers, some paid databases and many others.
Key Players
Some of the key players in the global cruciate ligament diagnosis & treatment market are Stryker Corporation (U.S.), Arthrex, Inc. (U.S.), Zimmer Biomet (U.S.), DePuy Synthes, Inc. (U.S.), CONMED Corporation (U.S.), Smith & Nephew plc. (U.S.), DJO Global Inc. (U.S.), Breg, Inc. (U.S.), Bauerfeind AG (Germany), Össur hf. (Iceland), BSN Medical GmbH (Germany), 3M Company (U.S.), Otto Bock Healthcare GmbH (Germany), THUASNE SA (France), medi GmbH & Co. KG (Germany), DeRoyal Industries Inc. (U.S.), Corin Group (UK), United Orthopedic Corporation (Taiwan), Exactech Inc. (U.S.), Japan Medical Dynamic Marketing (Japan), Tornier Inc. (U.S.), and others.
Segmentation
The global cruciate ligament diagnosis and treatment market is segmented on the basis of type, injury type, product, diagnosis, treatment, and end-user.
Based on type, the global cruciate ligament diagnosis and treatment market is classified as Posterior Cruciate Ligament (PCL) and Anterior Cruciate Ligament (ACL).
The segments for injury type for the global cruciate ligament diagnosis and treatment market are classified as grade I, grade II, and grade III.
On the basis of product, the global cruciate ligament diagnosis and treatment market is classified as cemented implants, cement-less implants, partial implants, and revision implants.
Based on indication, the global cruciate ligament diagnosis and treatment market is classified as osteoarthritis, rheumatoid arthritis, trauma, and others.
The diagnosis segment for the global cruciate ligament diagnosis and treatment market is classified as imaging others. The imaging segment is further classified as Magnetic Resonance Imaging (MRI), ultrasound, laparoscopy, and others.
Based on treatment, the global cruciate ligament diagnosis and treatment market is classified as surgery, therapies, devices, and others. Surgery can be further sub-divided into arthroscopy, Anterior Cruciate Ligament (ACL) reconstruction, and others. The therapies include rehabilitation and physical therapies. The devices include elastic bandages and others.
On the basis of end-user, the global cruciate ligament diagnosis and treatment market is classified as hospitals, orthopedic clinics, Ambulatory Surgical Centers (ASC), and others.
Geographically, the global cruciate ligament diagnosis and treatment market has been segmented into America, Europe, Asia Pacific, and the Middle East and Africa. The American cruciate ligament diagnosis and treatment market is further segmented into North America and South America. North America is further classified as the U.S. and Canada.
The European cruciate ligament diagnosis and treatment market is segmented into Western Europe and Eastern Europe. Western Europe is further classified as Germany, France, the U.K., Italy, Spain, and the Rest of Western Europe.
The Asia Pacific cruciate ligament diagnosis and treatment market is segmented into Japan, China, India, Republic of Korea, Australia, and the Rest of Asia Pacific.
The Middle Eastern and African cruciate ligament diagnosis and treatment market is segmented into the Middle East and Africa.
Regional Market Summary
Global Cruciate Ligament Diagnosis & Treatment Market, by Region Market Share, 2017 (%)
Source: MRFR Analysis
The Americas dominates the cruciate ligament diagnosis and treatment market owing to the rising prevalence of osteoarthritis among the elderly population, well-developed surgical technology, high healthcare expenditure, and the presence of the leading players.
This market is attracting many key participants such as Stryker Corporation; Zimmer Biomet; DePuySynthes, Inc., Arthrex, Inc.; Smith & Nephew plc; and CONMED Corporation. For instance, Smith & Nephew acquired the diversified product portfolio for orthopedic soft tissue repair from ArthroCare Corporation further strengthening the position of the company in the global market.
Europe holds the second position in the cruciate ligament diagnosis and treatment market. It is expected that the rising contribution towards research and development for the development of surgical implants and increasing competition among marketers for drug launch are likely to drive the European cruciate ligament diagnosis and treatment market. For instance, in May 2017 Ablynx, a biopharmaceutical company headquartered in Belgium, announced the completion of a preclinical package for a novel nanobody, ALX-1141 for the treatment of osteoarthritis. Merck will now be responsible for the further clinical development of the molecule.
Asia Pacific is the fastest growing cruciate ligament diagnosis and treatment market owing to a huge patient pool, increasing demand for treatments, and rising healthcare expenditure. For instance, in July 2017, Kolon Pharmaceutical got the approval for the World's first cell and gene therapy for knee osteoarthritis in Korea. Thus, all these factors are cumulatively responsible for the growth in this region.
The Middle East and Africa holds the lowest share of the global cruciate ligament diagnosis and treatment market due to low development, lack of technical knowledge, and poor medical facilities.
Global Cruciate Ligament Diagnosis & Treatment Market, by type
- Posterior Cruciate Ligament (PCL)
- Anterior Cruciate Ligament (ACL)
Global Cruciate Ligament Diagnosis & Treatment Market, by Injury type
- Grade I
- Grade II
- Grade III.
Global Cruciate Ligament Diagnosis & Treatment Market, by Indication
- Osteoarthritis
- Rheumatoid arthritis
- Trauma
Global Cruciate Ligament Diagnosis & Treatment Market, by Product
- Cemented implants
- Cement-less implants
- Partial implants
- Revision implants.
Global Cruciate Ligament Diagnosis & Treatment Market, by Diagnosis
- Imaging
- Magnetic Resonance Imaging (MRI)’
- Ultrasound
- Laparoscopy
- Others
Global Cruciate Ligament Diagnosis & Treatment Market, by Treatment
- Surgery
- Arthroscopy
- Anterior Cruciate Ligament (ACL) reconstruction
- Others
- Therapies
- Rehabilitation
- Physical Therapies
- Devices
- Elastic Bandages
- Others
Global Cruciate Ligament Diagnosis & Treatment Market, by End-user
- Hospitals
- Orthopedic Clinics
- Ambulatory Surgical Center (ASC)
Global Cruciate Ligament Diagnosis & Treatment Market, by Region
- Americas
- North America
- U.S.
- Canada
- South America
- Europe
- Western Europe
- Germany
- France
- Italy
- Spain
- U.K.
- Rest of Western Europe
- Eastern Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- Republic of Korea
- Rest of Asia Pacific
- The Middle East & Africa
- Middle East
- Africa
Company Profiles
- Stryker Corporation
- Arthrex, Inc.
- Zimmer Biomet
- DePuy Synthes, Inc.
- CONMED Corporation
- Smith & Nephew plc.
- DJO Global Inc.
- Breg, Inc.
- Bauerfeind AG
Frequently Asked Questions (FAQ) :
Major products used in cruciate ligament diagnosis and treatment include cemented implants, cement-less implants, partial implants, and revision implants.
Global cruciate ligament diagnosis and treatment market is expected to exhibit a strong 6.4% CAGR over the forecast period from 2018 to 2023.
The growing prevalence of sports-related cruciate ligament injuries is the major driver for the cruciate ligament diagnosis and treatment market.
The Americas dominate the global cruciate ligament diagnosis and treatment market.
Leading players in the cruciate ligament diagnosis and treatment market include Breg Inc., Stryker, and Arthrex, among others.
Table of Content
1. Report Prologue
2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
6. Global Cruciate Ligament Diagnosis and Treatment Market, by Type
6.1 Introduction
6.2 Posterior Cruciate Ligament (PCL)
Market Estimates & Forecast, 2018–2023
Market Estimates & Forecast, by Region/Country, 2018–2023
6.3 Anterior Cruciate Ligament (ACL)
Market Estimates & Forecast, 2018–2023
Market Estimates & Forecast, by Region/Country, 2018–2023
6.3.1 Clinical
6.3.2 Non-Clinical
7. Global Cruciate Ligament Diagnosis and Treatment Market, by Injury Type
7.1 Introduction
7.2 Grade I
Market Estimates & Forecast, 2018–2023
Market Estimates & Forecast, by Region/Country, 2018–2023
7.3 Grade II
Market Estimates & Forecast, 2018–2023
Market Estimates & Forecast, by Region/Country, 2018–2023
7.4 Grade III
Market Estimates & Forecast, 2018–2023
Market Estimates & Forecast, by Region/Country, 2018–2023
8. Global Cruciate Ligament Diagnosis and Treatment Market, by Indication
8.1 Introduction
8.2 Osteoarthritis
Market Estimates & Forecast, 2018–2023
Market Estimates & Forecast, by Region/Country, 2018–2023
8.3 Rheumatoid Arthritis
Market Estimates & Forecast, 2018–2023
Market Estimates & Forecast, by Region/Country, 2018–2023
8.4 Trauma
Market Estimates & Forecast, 2018–2023
Market Estimates & Forecast, by Region/Country, 2018–2023
8.5 Others
Market Estimates & Forecast, 2018–2023
Market Estimates & Forecast, by Region/Country, 2018–2023
9. Global Cruciate Ligament Diagnosis and Treatment Market, by Product
9.1 Introduction
9.2 Cemented implants
Market Estimates & Forecast, 2018–2023
Market Estimates & Forecast, by Region/Country, 2018–2023
9.3 Cement-less implants
Market Estimates & Forecast, 2018–2023
Market Estimates & Forecast, by Region/Country, 2018–2023
9.4 Partial Implants
Market Estimates & Forecast, 2018–2023
Market Estimates & Forecast, by Region/Country, 2018–2023
9.5 Revision Implants
Market Estimates & Forecast, 2018–2023
Market Estimates & Forecast, by Region/Country, 2018–2023
10. Global Cruciate Ligament Diagnosis and Treatment Market, by Diagnosis
10.1 Introduction
10.2 Imaging
Market Estimates & Forecast, 2018–2023
Market Estimates & Forecast, by Region/Country, 2018–2023
10.2.1 Magnetic Resonance Imaging (MRI)
10.2.2 Ultrasound
10.2.3 Laparoscopy
10.2.4 Others
10.3 Others
Market Estimates & Forecast, 2018–2023
Market Estimates & Forecast, by Region/Country, 2018–2023
11. Global Cruciate Ligament Diagnosis and Treatment Market, by Treatment
11.1 Introduction
11.2 Surgery
Market Estimates & Forecast, 2018–2023
Market Estimates & Forecast, by Region/Country, 2018–2023
11.2.1 Arthroscopy
11.2.2 Anterior Cruciate Ligament (ACL) reconstruction
11.2.3 Others
11.3 Therapies
Market Estimates & Forecast, 2018–2023
Market Estimates & Forecast, by Region/Country, 2018–2023
11.3.1 Rehabilitation’
11.3.2 Physical Therapies
11.4 Devices
Market Estimates & Forecast, 2018–2023
Market Estimates & Forecast, by Region/Country, 2018–2023
11.3.1 Elastic Bandages
11.3.2 Others
11.5 Others
Market Estimates & Forecast, 2018–2023
Market Estimates & Forecast, by Region/Country, 2018–2023
12. Global Cruciate Ligament Diagnosis and Treatment Market, by End-User
9.1 Introduction
12.2 Hospitals
Market Estimates & Forecast, 2018–2023
Market Estimates & Forecast, by Region/Country, 2018–2023
12.3 Orthopedic Clinics
Market Estimates & Forecast, 2018–2023
Market Estimates & Forecast, by Region/Country, 2018–2023
12.4 Ambulatory Surgical Center (ASC)
Market Estimates & Forecast, 2018–2023
Market Estimates & Forecast, by Region/Country, 2018–2023
13 Global Cruciate Ligament Diagnosis and Treatment Market, by Region
13.1 Introduction
13.2 Americas
• Market Estimates & Forecast, by Region, 2018–2023
• Market Estimates & Forecast, by Type, 2018–2023
• Market Estimates & Forecast, by Injury type, 2018–2023
• Market Estimates & Forecast, by Indication, 2018–2023
• Market Estimates & Forecast, by Diagnosis, 2018–2023
• Market Estimates & Forecast, by Treatment, 2018–2023
• Market Estimates & Forecast, by End-User, 2018–2023
13.2.1 North America
• Market Estimates & Forecast, by Region, 2018–2023
• Market Estimates & Forecast, by Type, 2018–2023
• Market Estimates & Forecast, by Injury type, 2018–2023
• Market Estimates & Forecast, by Indication, 2018–2023
• Market Estimates & Forecast, by Diagnosis, 2018–2023
• Market Estimates & Forecast, by Treatment, 2018–2023
• Market Estimates & Forecast, by End-User, 2018–2023
13.2.1.1 U.S.
• Market Estimates & Forecast, by Region, 2018–2023
• Market Estimates & Forecast, by Type, 2018–2023
• Market Estimates & Forecast, by Injury type, 2018–2023
• Market Estimates & Forecast, by Indication, 2018–2023
• Market Estimates & Forecast, by Diagnosis, 2018–2023
• Market Estimates & Forecast, by Treatment, 2018–2023
• Market Estimates & Forecast, by End-User, 2018–2023
13.2.1.2 Canada
• Market Estimates & Forecast, by Region, 2018–2023
• Market Estimates & Forecast, by Type, 2018–2023
• Market Estimates & Forecast, by Injury type, 2018–2023
• Market Estimates & Forecast, by Indication, 2018–2023
• Market Estimates & Forecast, by Diagnosis, 2018–2023
• Market Estimates & Forecast, by Treatment, 2018–2023
• Market Estimates & Forecast, by End-User, 2018–2023
13.2.2 South America
• Market Estimates & Forecast, by Region, 2018–2023
• Market Estimates & Forecast, by Type, 2018–2023
• Market Estimates & Forecast, by Injury type, 2018–2023
• Market Estimates & Forecast, by Indication, 2018–2023
• Market Estimates & Forecast, by Diagnosis, 2018–2023
• Market Estimates & Forecast, by Treatment, 2018–2023
• Market Estimates & Forecast, by End-User, 2018–2023
13.3 Europe
• Market Estimates & Forecast, by Region, 2018–2023
• Market Estimates & Forecast, by Type, 2018–2023
• Market Estimates & Forecast, by Injury type, 2018–2023
• Market Estimates & Forecast, by Indication, 2018–2023
• Market Estimates & Forecast, by Diagnosis, 2018–2023
• Market Estimates & Forecast, by Treatment, 2018–2023
• Market Estimates & Forecast, by End-User, 2018–2023
13.3.1 Western Europe
• Market Estimates & Forecast, by Region, 2018–2023
• Market Estimates & Forecast, by Type, 2018–2023
• Market Estimates & Forecast, by Injury type, 2018–2023
• Market Estimates & Forecast, by Indication, 2018–2023
• Market Estimates & Forecast, by Diagnosis, 2018–2023
• Market Estimates & Forecast, by Treatment, 2018–2023
• Market Estimates & Forecast, by End-User, 2018–2023
13.3.1.1 Germany
• Market Estimates & Forecast, by Region, 2018–2023
• Market Estimates & Forecast, by Type, 2018–2023
• Market Estimates & Forecast, by Injury type, 2018–2023
• Market Estimates & Forecast, by Indication, 2018–2023
• Market Estimates & Forecast, by Diagnosis, 2018–2023
• Market Estimates & Forecast, by Treatment, 2018–2023
• Market Estimates & Forecast, by End-User, 2018–2023
13.3.1.2 France
• Market Estimates & Forecast, by Region, 2018–2023
• Market Estimates & Forecast, by Type, 2018–2023
• Market Estimates & Forecast, by Injury type, 2018–2023
• Market Estimates & Forecast, by Indication, 2018–2023
• Market Estimates & Forecast, by Diagnosis, 2018–2023
• Market Estimates & Forecast, by Treatment, 2018–2023
• Market Estimates & Forecast, by End-User, 2018–2023
13.3.1.3 U.K.
• Market Estimates & Forecast, by Region, 2018–2023
• Market Estimates & Forecast, by Type, 2018–2023
• Market Estimates & Forecast, by Injury type, 2018–2023
• Market Estimates & Forecast, by Indication, 2018–2023
• Market Estimates & Forecast, by Diagnosis, 2018–2023
• Market Estimates & Forecast, by Treatment, 2018–2023
• Market Estimates & Forecast, by End-User, 2018–2023
13.3.1.4 Italy
• Market Estimates & Forecast, by Region, 2018–2023
• Market Estimates & Forecast, by Type, 2018–2023
• Market Estimates & Forecast, by Injury type, 2018–2023
• Market Estimates & Forecast, by Indication, 2018–2023
• Market Estimates & Forecast, by Diagnosis, 2018–2023
• Market Estimates & Forecast, by Treatment, 2018–2023
• Market Estimates & Forecast, by End-User, 2018–2023
13.3.1.5 Spain
• Market Estimates & Forecast, by Region, 2018–2023
• Market Estimates & Forecast, by Type, 2018–2023
• Market Estimates & Forecast, by Injury type, 2018–2023
• Market Estimates & Forecast, by Indication, 2018–2023
• Market Estimates & Forecast, by Diagnosis, 2018–2023
• Market Estimates & Forecast, by Treatment, 2018–2023
• Market Estimates & Forecast, by End-User, 2018–2023
13.3.1.6 Rest of Western Europe
• Market Estimates & Forecast, by Region, 2018–2023
• Market Estimates & Forecast, by Type, 2018–2023
• Market Estimates & Forecast, by Injury type, 2018–2023
• Market Estimates & Forecast, by Indication, 2018–2023
• Market Estimates & Forecast, by Diagnosis, 2018–2023
• Market Estimates & Forecast, by Treatment, 2018–2023
• Market Estimates & Forecast, by End-User, 2018–2023
13.3.2 Eastern Europe
• Market Estimates & Forecast, by Region, 2018–2023
• Market Estimates & Forecast, by Type, 2018–2023
• Market Estimates & Forecast, by Injury type, 2018–2023
• Market Estimates & Forecast, by Indication, 2018–2023
• Market Estimates & Forecast, by Diagnosis, 2018–2023
• Market Estimates & Forecast, by Treatment, 2018–2023
• Market Estimates & Forecast, by End-User, 2018–2023
13.4 Asia Pacific
• Market Estimates & Forecast, by Region, 2018–2023
• Market Estimates & Forecast, by Type, 2018–2023
• Market Estimates & Forecast, by Injury type, 2018–2023
• Market Estimates & Forecast, by Indication, 2018–2023
• Market Estimates & Forecast, by Diagnosis, 2018–2023
• Market Estimates & Forecast, by Treatment, 2018–2023
• Market Estimates & Forecast, by End-User, 2018–2023
13.4.1 Japan
• Market Estimates & Forecast, by Region, 2018–2023
• Market Estimates & Forecast, by Type, 2018–2023
• Market Estimates & Forecast, by Injury type, 2018–2023
• Market Estimates & Forecast, by Indication, 2018–2023
• Market Estimates & Forecast, by Diagnosis, 2018–2023
• Market Estimates & Forecast, by Treatment, 2018–2023
• Market Estimates & Forecast, by End-User, 2018–2023
13.4.2 China
• Market Estimates & Forecast, by Region, 2018–2023
• Market Estimates & Forecast, by Type, 2018–2023
• Market Estimates & Forecast, by Injury type, 2018–2023
• Market Estimates & Forecast, by Indication, 2018–2023
• Market Estimates & Forecast, by Diagnosis, 2018–2023
• Market Estimates & Forecast, by Treatment, 2018–2023
• Market Estimates & Forecast, by End-User, 2018–2023
13.4.3 India
• Market Estimates & Forecast, by Region, 2018–2023
• Market Estimates & Forecast, by Type, 2018–2023
• Market Estimates & Forecast, by Injury type, 2018–2023
• Market Estimates & Forecast, by Indication, 2018–2023
• Market Estimates & Forecast, by Diagnosis, 2018–2023
• Market Estimates & Forecast, by Treatment, 2018–2023
• Market Estimates & Forecast, by End-User, 2018–2023
13.4.4 Australia
• Market Estimates & Forecast, by Region, 2018–2023
• Market Estimates & Forecast, by Type, 2018–2023
• Market Estimates & Forecast, by Injury type, 2018–2023
• Market Estimates & Forecast, by Indication, 2018–2023
• Market Estimates & Forecast, by Diagnosis, 2018–2023
• Market Estimates & Forecast, by Treatment, 2018–2023
• Market Estimates & Forecast, by End-User, 2018–2023
13.4.5 Republic of Korea
• Market Estimates & Forecast, by Region, 2018–2023
• Market Estimates & Forecast, by Type, 2018–2023
• Market Estimates & Forecast, by Injury type, 2018–2023
• Market Estimates & Forecast, by Indication, 2018–2023
• Market Estimates & Forecast, by Diagnosis, 2018–2023
• Market Estimates & Forecast, by Treatment, 2018–2023
• Market Estimates & Forecast, by End-User, 2018–2023
13.4.6 Rest of Asia Pacific
• Market Estimates & Forecast, by Region, 2018–2023
• Market Estimates & Forecast, by Type, 2018–2023
• Market Estimates & Forecast, by Injury type, 2018–2023
• Market Estimates & Forecast, by Indication, 2018–2023
• Market Estimates & Forecast, by Diagnosis, 2018–2023
• Market Estimates & Forecast, by Treatment, 2018–2023
• Market Estimates & Forecast, by End-User, 2018–2023
13.5 The Middle East & Africa
• Market Estimates & Forecast, by Region, 2018–2023
• Market Estimates & Forecast, by Type, 2018–2023
• Market Estimates & Forecast, by Injury type, 2018–2023
• Market Estimates & Forecast, by Indication, 2018–2023
• Market Estimates & Forecast, by Diagnosis, 2018–2023
• Market Estimates & Forecast, by Treatment, 2018–2023
• Market Estimates & Forecast, by End-User, 2018–2023
13.5.1 The Middle East
• Market Estimates & Forecast, by Region, 2018–2023
• Market Estimates & Forecast, by Type, 2018–2023
• Market Estimates & Forecast, by Injury type, 2018–2023
• Market Estimates & Forecast, by Indication, 2018–2023
• Market Estimates & Forecast, by Diagnosis, 2018–2023
• Market Estimates & Forecast, by Treatment, 2018–2023
• Market Estimates & Forecast, by End-User, 2018–2023
13.5.2 Africa
• Market Estimates & Forecast, by Region, 2018–2023
• Market Estimates & Forecast, by Type, 2018–2023
• Market Estimates & Forecast, by Injury type, 2018–2023
• Market Estimates & Forecast, by Indication, 2018–2023
• Market Estimates & Forecast, by Diagnosis, 2018–2023
• Market Estimates & Forecast, by Treatment, 2018–2023
• Market Estimates & Forecast, by End-User, 2018–2023
14 Company Landscape
14.1 Introduction
14.2 Market Share Analysis
14.3 Key Development & Strategies
14.3.1 Key Developments
15 Company Profiles
15.1 Stryker Corporation
15.1.1 Company Overview
15.1.2 Type Overview
15.1.3 Financials
15.1.4 SWOT Analysis
15.2 Arthrex, Inc.
15.2.1 Company Overview
15.2.2 Product Overview
15.2.3 Financial Overview
15.2.4 Key Developments
15.2.5 SWOT Analysis
15.3 Zimmer Biomet
15.3.1 Company Overview
15.3.2 Type Overview
15.3.3 Financial Overview
15.3.4 Key Development
15.3.5 SWOT Analysis
15.4 DePuy Synthes, Inc.
15.4.1 Company Overview
15.4.2 Type/Business Segment Overview
15.4.3 Financial Overview
15.4.4 Key Development
15.4.5 SWOT Analysis
15.5 CONMED Corporation
15.5.1 Company Overview
15.5.2 Type Overview
15.5.3 Financial overview
15.5.4 Key Developments
15.6 Smith & Nephew plc.
15.6.1 Company Overview
15.6.2 Type Overview
15.6.3 Financial Overview
15.6.4 Key Developments
15.7 DJO Global Inc.
15.7.1 Overview
15.7.2 Type Overview
15.7.3 Financials
15.7.4 Key Developments
15.7.5 SWOT Analysis
15.8 Breg, Inc.
15.8.1 Overview
15.8.2 Type Overview
15.8.3 Financials
15.8.4 Key Developments
15.8.5 SWOT Analysis
15.9 Bauerfeind AG
15.9.1 Overview
15.9.2 Type Overview
15.9.3 Financials
15.9.4 Key Developments
15.9.5 SWOT Analysis
15.10 Össur hf.
15.10.1 Overview
15.10.2 Type Overview
15.10.3 Financials
15.10.4 Key Developments
15.10.5 SWOT Analysis
15.11 DeRoyal Industries, Inc.
15.11.1 Overview
15.11.2 Type Overview
15.11.3 Financials
15.11.4 Key Developments
15.11.5 SWOT Analysis
15.12 BSN Medical GmbH
15.15.1 Overview
15.15.2 Type Overview
15.15.3 Financials
15.15.4 Key Developments
15.15.5 SWOT Analysis
15.13 3M Company
15.13.1 Overview
15.13.2 Type Overview
15.13.3 Financials
15.13.4 Key Developments
15.13.5 SWOT Analysis
16 Appendix
LIST OF TABLES
Table 1 Cruciate Ligament Diagnosis and Treatment Industry Synopsis, 2018–2023
Table 2 Global Cruciate Ligament Diagnosis and Treatment Market Estimates and Forecast, 2018–2023, (USD Million)
Table 3 Global Cruciate Ligament Diagnosis and Treatment Market, by Region, 2018–2023, (USD Million)
Table 5 Global Cruciate Ligament Diagnosis and Treatment Market, by Type, 2018–2023, (USD Million)
Table 5 Global Cruciate Ligament Diagnosis and Treatment Market, by Injury type, 2018–2023, (USD Million)
Table 6 Global Cruciate Ligament Diagnosis and Treatment Market, by Indication, 2018–2023, (USD Million)
Table 7 Global Cruciate Ligament Diagnosis and Treatment Market, by End-User, 2018–2023, (USD Million)
Table 8 North America Cruciate Ligament Diagnosis and Treatment Market, by Type, 2018–2023, (USD Million)
Table 9 North America Cruciate Ligament Diagnosis and Treatment Market, by Indication, 2018–2023, (USD Million)
Table 9 North America Cruciate Ligament Diagnosis and Treatment Market, by Injury type, 2018–2023, (USD Million)
Table 10 North America Cruciate Ligament Diagnosis and Treatment Market, by End-User, 2018–2023, (USD Million)
Table 11 U.S. Cruciate Ligament Diagnosis and Treatment Market, by Type, 2018–2023, (USD Million)
Table 12 U.S. Cruciate Ligament Diagnosis and Treatment Market, by Indication, 2018–2023, (USD Million)
Table 12 U.S. Cruciate Ligament Diagnosis and Treatment Market, by Injury type, 2018–2023, (USD Million)
Table 13 U.S. Cruciate Ligament Diagnosis and Treatment Market, by End-User, 2018–2023, (USD Million)
Table 14 Canada Cruciate Ligament Diagnosis and Treatment Market, by Type, 2018–2023, (USD Million)
Table 14 Canada Cruciate Ligament Diagnosis and Treatment Market, by Injury type, 2018–2023, (USD Million)
Table 15 Canada Cruciate Ligament Diagnosis and Treatment Market, by Indication, 2018–2023, (USD Million)
Table 16 Canada Cruciate Ligament Diagnosis and Treatment Market, by End-User, 2018–2023, (USD Million)
Table 17 South America Cruciate Ligament Diagnosis and Treatment Market, by Type, 2018–2023, (USD Million)
Table 18 South America Cruciate Ligament Diagnosis and Treatment Market, by Indication, 2018–2023, (USD Million)
Table 19 South America Cruciate Ligament Diagnosis and Treatment Market, by End-User, 2018–2023, (USD Million)
Table 20 Europe Cruciate Ligament Diagnosis and Treatment Market, by Type, 2018–2023, (USD Million)
Table 21 Europe Cruciate Ligament Diagnosis and Treatment Market, by Indication, 2018–2023, (USD Million)
Table 22 Europe Cruciate Ligament Diagnosis and Treatment Market, by End-User, 2018–2023, (USD Million)
Table 23 Western Europe Cruciate Ligament Diagnosis and Treatment Market, by Type, 2018–2023, (USD Million)
Table 24 Western Europe Cruciate Ligament Diagnosis and Treatment Market, by Indication, 2018–2023, (USD Million)
Table 25 Western Europe Cruciate Ligament Diagnosis and Treatment Market, by End-User, 2018–2023, (USD Million)
Table 26 Eastern Europe Cruciate Ligament Diagnosis and Treatment Market, by Type, 2018–2023, (USD Million)
Table 27 Eastern Europe Cruciate Ligament Diagnosis and Treatment Market, by Indication, 2018–2023, (USD Million)
Table 28 Eastern Europe Cruciate Ligament Diagnosis and Treatment Market, by End-User, 2018–2023, (USD Million)
Table 29 Asia Pacific Cruciate Ligament Diagnosis and Treatment Market, by Type, 2018–2023, (USD Million)
Table 30 Asia Pacific Cruciate Ligament Diagnosis and Treatment Market, by Indication, 2018–2023, (USD Million)
Table 31 Asia Pacific Cruciate Ligament Diagnosis and Treatment Market, by End-User, 2018–2023, (USD Million)
Table 32 Middle East & Africa Cruciate Ligament Diagnosis and Treatment Market, by Type, 2018–2023, (USD Million)
Table 33 Middle East & Africa Cruciate Ligament Diagnosis and Treatment Market, by Injury type, 2018–2023, (USD Million)
Table 34 Middle East & Africa Cruciate Ligament Diagnosis and Treatment Market, by End-User, 2018–2023, (USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for Global Cruciate Ligament Diagnosis and Treatment Market
Figure 3 Segmentation Market Dynamics for Cruciate Ligament Diagnosis and Treatment Market
Figure 4 Global Cruciate Ligament Diagnosis and Treatment Market Share, by Type 2016
Figure 5 Global Cruciate Ligament Diagnosis and Treatment Market Share, by Injury type 2016
Figure 6 Global Cruciate Ligament Diagnosis and Treatment Market Share, by End-User, 2016
Figure 7 Global Cruciate Ligament Diagnosis and Treatment Market Share, by Region, 2016
Figure 8 North America Cruciate Ligament Diagnosis and Treatment Market Share, by Country, 2016
Figure 9 Europe Cruciate Ligament Diagnosis and Treatment Market Share, by Country, 2016
Figure 10 Asia Pacific Cruciate Ligament Diagnosis and Treatment Market Share, by Country, 2016
Figure 11 Middle East & Africa Cruciate Ligament Diagnosis and Treatment Market Share, by Country, 2016
Figure 12 Global Cruciate Ligament Diagnosis and Treatment Market: Company Share Analysis, 2016 (%)
Figure 13 Stryker Corporation: Key Financials
Figure 14 Stryker Corporation: Segmental Revenue
Figure 16 Stryker Corporation: Geographical Revenue
Figure 17 Zimmer Biomet. Key Financials
Figure 18 Zimmer Biomet: Segmental Revenue
Figure 19 Zimmer Biomet: Geographical Revenue
Figure 20 Ortho Clinical Diagnostics: Key Financials
Figure 21 Ortho Clinical Diagnostics: Segmental Revenue
Figure 22 Ortho Clinical Diagnostics: Geographical Revenue
Figure 23 DePuy Synthes, Inc.: Key Financials
Figure 24 DePuy Synthes, Inc.: Segmental Revenue
Figure 25 DePuy Synthes, Inc.: Geographical Revenue
Figure 26 Smith & Nephew plc.: Key Financials
Figure 27 Smith & Nephew plc.: Segmental Revenue
Figure 28 Smith & Nephew plc. Geographical Revenue
Figure 29 Arthrex, Inc. Key Financials
Figure 30 Arthrex, Inc. Segmental Revenue
Figure 31 Arthrex, Inc. Geographical Revenue
